Symptom Resolution and Meaningful Improvement in Quality of Life With Risankizumab in Patients With Ulcerative Colitis: Post Hoc Analysis of the Randomized INSPIRE and COMMAND Studies

RZB treatment improved UC-related symptoms and HRQoL outcomes compared with PBO in patients with UC.

Authors

Remo Panaccione (ORCID: https://orcid.org/0000-0002-5247-940X)
Marla C. Dubinsky (ORCID: https://orcid.org/0000-0003-4968-5795)
Parambir S. Dulai (ORCID: https://orcid.org/0000-0002-9514-2321)
Lorenzo Rizzo (ORCID: https://orcid.org/0000-0002-8778-8317)
Nidhi Shukla (ORCID: https://orcid.org/0000-0002-7581-3861)
Julián Panés (ORCID: https://orcid.org/0000-0002-4971-6902)
Dolly Sharma
Silvio Danese (ORCID: https://orcid.org/0000-0001-7341-1351)
Jasmina Kalabic (ORCID: https://orcid.org/0009-0007-4698-1042)
Cécile Holweg (ORCID: https://orcid.org/0000-0002-8983-6669)
Joana Torres (ORCID: https://orcid.org/0000-0003-2895-5821)
Satoshi Tanida (ORCID: https://orcid.org/0000-0003-0068-1283)
Jyun‐Heng Lai (ORCID: https://orcid.org/0009-0007-7420-2085)
Corey A. Siegel (ORCID: https://orcid.org/0000-0002-2240-6605)

Northwestern University (US)
Austin College (US)
Dartmouth Institute for Health Policy and Clinical Practice (US)
University of Lisbon (PT)
Vita-Salute San Raffaele University (IT)
University of Calgary (CA)
AbbVie (United States) (US)
Nagoya City University (JP)
Hospital Clínic de Barcelona (ES)
Dartmouth Psychiatric Research Center (US)
Troy Gastroenterology (US)
AbbVie (Germany) (DE)
Hospital da Luz (PT)
Hospital Beatriz Ângelo (PT)
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
IRCCS Ospedale San Raffaele (IT)
Northwestern Medicine (US)
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
Dartmouth Health (US)
The University of Texas at Austin (US)
Icahn School of Medicine at Mount Sinai (US)